ICON plc in den Nachrichten
Beratung und Dienstleistungen zur Arzneimittelentwicklung
Tamtam hat 20 aktuelle Artikel über ICON plc gefunden.
- ICON PLC (ICLR) Is Leveraging AI to Accelerate Clinical Trials
- U.S. Markets Rose Wednesday; Icon PLC Topped Leaders
- Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
- Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for
- Icon (ICLR) Stock Forecast and Price Target 2026 $ICLR
- BofA Securities Upgrades Icon PLC (ICLR) to Neutral, Lifts Price Target Amid Positive CRO Outlook
- ICON plc Stock 12‑Month Price Target Raised to $187.81, Implies 14% Upside
- Results arrive after market close October 27 for ICON (ICLR), with an earnings call October 28.
- Is Icon PLC (ICLR) a Bargain After 3.9% Drop? GF Value Says Unde
- ICON plc (ICLR) rises as investors appear to lean on backlog, guidance, and recent filings
- S&P 500 Futures Rise in Premarket Trading; Xenon Pharmaceuticals, Icon PLC Lag
- White & Case advises ICON on its US$2.15 billion notes offering and related secured debt refinancing
- Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
- ICON plc (ICLR) Surged 57% in Q2 After Accounting Clarity
- Icon PLC (ICLR) Lags Q2 Earnings Estimates
- Icon PLC (ICLR) Up 5.8% Since Last Earnings Report: Can It Continue?
- Icon defends claim it left investors with ‘billions in losses’
- Earnings Preview: Icon PLC (ICLR) Q2 Earnings Expected to Decline
- ICON plc Selects Microsoft (MSFT) As Preferred Technology Partner
- Greenskeeper Asset Management Increased Its Holdings in ICON Plc (ICLR) Amid Market Fear
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie ICON plc?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden